Virtual screening and molecular dynamics simulation study of plant protease inhibitors against SARS-CoV-2 envelope protein. (2022)

• Record Type: Journal Article
• Authors: Kirar, Manisha; Singh, Hitesh; Sehrawat, Neelam
• Is Part Of: Informatics in medicine unlocked. Volume 30(2022)
• Publication Date: 2022
• Subjects: Plant protease inhibitors -- Envelope protein -- SARS-CoV-2 -- Molecular docking -- Molecular dynamics simulation etc; Medical informatics -- Periodicals; 610.285
• DOI: 10.1016/j.imu.2022.100909
• Languages: English
• ISSNs: 2352-9148

Abstract

Abstract: Due to the outbreak of a new strain of pandemic coronavirus, there is a huge loss of economy and health. In 2021, some vaccines are recommended as emergency licensed vaccines to protect against the virus, and efforts are continuously ongoing to evaluate the vaccine safety measures for licensed vaccines. Recently, there was an increase in the cases of a new variant of coronavirus (omicron). Envelope protein plays an important role in virus packaging and assembly. If viral assembly is blocked, there is less chance of spreading the infection to another cell.In the present study, the plant protease inhibitors (PPIs) were screened against the envelope protein of SARS CoV 2. The structures were downloaded from the protein data bank. The plant protease inhibitors cystatin-I, Eravatmin, squash, Kunitz, Bowman-Birk, Alpha-amylase inhibitors, and potato serine protease inhibitors were screened and out of them Kunitz, alpha-amylase, and squash protease inhibitors have shown maximum binding energy. The molecular dynamics simulation was performed for docked complexes showing the lowest binding energy by NMA (normal mode analysis) to visualize the motion and stability of complexes. These plant-based protease inhibitors are a good target to fight against the new emerging strain of coronavirus because plant extracted compounds are natural and there is fewer side effect than synthetic compounds.